Thuja Capital at BIO-Europe 2026
Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website
Thuja Capital takes part in 2 sessions at BIO-Europe 2026 in Cologne. Its sessions cover building a career in business development and a survey of the therapeutic landscape informed by analyst research, the latter shared with Ipsen, Medicxi and AlphaSense.
| Organization | BIO-Europe 2026 Attendance |
|---|---|
Thuja Capital Utrecht, Netherlands | |
Early-stage venture capital firm investing in European life science companies. | Talk Mon Nov 9 09:00–10:00 Building Your BD Career: What Really Moves the Needle What it takes to build a career in drug licensing and partnership deals, from scientific and financial skills to credibility and contacts. Panel Mon Nov 9 13:00–13:45 The therapeutic landscape backed by analyst insights Which disease areas analysts rate most promising for new drugs and investment, and how new science and rule changes are reshaping them. |
Instantly find 20 buyers from Thuja Capital
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction